FR2506310B1 - - Google Patents

Info

Publication number
FR2506310B1
FR2506310B1 FR8110219A FR8110219A FR2506310B1 FR 2506310 B1 FR2506310 B1 FR 2506310B1 FR 8110219 A FR8110219 A FR 8110219A FR 8110219 A FR8110219 A FR 8110219A FR 2506310 B1 FR2506310 B1 FR 2506310B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8110219A
Other languages
French (fr)
Other versions
FR2506310A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmindustrie
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Priority to FR8110219A priority Critical patent/FR2506310A1/fr
Priority to IL65512A priority patent/IL65512A/xx
Priority to US06/374,366 priority patent/US4435410A/en
Priority to CA000402161A priority patent/CA1183849A/fr
Priority to GR68056A priority patent/GR74753B/el
Priority to DE8282400872T priority patent/DE3261441D1/de
Priority to EP82400872A priority patent/EP0065908B1/fr
Priority to PT74916A priority patent/PT74916B/pt
Priority to AR289454A priority patent/AR231290A1/es
Priority to ZA823489A priority patent/ZA823489B/xx
Priority to MA19687A priority patent/MA19481A1/fr
Priority to HU821642A priority patent/HU188172B/hu
Priority to ES512472A priority patent/ES8307242A1/es
Priority to JP57086383A priority patent/JPS57200385A/ja
Priority to AU84042/82A priority patent/AU550319B2/en
Priority to DK230282A priority patent/DK230282A/da
Priority to NO821700A priority patent/NO821700L/no
Publication of FR2506310A1 publication Critical patent/FR2506310A1/fr
Priority to ES521432A priority patent/ES8402284A1/es
Application granted granted Critical
Publication of FR2506310B1 publication Critical patent/FR2506310B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR8110219A 1981-05-22 1981-05-22 ((alkyl- et alcenyl-3 piperidyl-4)-2 ethyl)-3 indoles et leur utilisation comme medicaments Granted FR2506310A1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR8110219A FR2506310A1 (fr) 1981-05-22 1981-05-22 ((alkyl- et alcenyl-3 piperidyl-4)-2 ethyl)-3 indoles et leur utilisation comme medicaments
IL65512A IL65512A (en) 1981-05-22 1982-04-16 3-(2-(3-alkyl and alkenyl-4-piperidyl)-ethyl)-indoles,their preparation and pharmaceutical compositions containing them
US06/374,366 US4435410A (en) 1981-05-22 1982-05-03 3-[2-(3-Alkyl and alkenyl-4-piperidyl)-ethyl]-indoles for inhibiting serotonin uptake and for releasing serotonin
CA000402161A CA1183849A (fr) 1981-05-22 1982-05-03 ¬alkyl- et alcenyl-3 piperidyl-4)-2 ethyl|-3 indoles et leur utilisation comme medicaments
GR68056A GR74753B (show.php) 1981-05-22 1982-05-04
DE8282400872T DE3261441D1 (en) 1981-05-22 1982-05-11 ((alkyl and alcenyl 3-piperidyl-4(-2-ethyl)-3 indoles, and their use as pharmaceutical preparations
EP82400872A EP0065908B1 (fr) 1981-05-22 1982-05-11 ((Alkyl- et alcényl-3 pipéridyl-4)-2 éthyl)-3 indoles et leur utilisation comme médicaments
PT74916A PT74916B (fr) 1981-05-22 1982-05-18 <(alkyl-et alcenyl-3 piperidyl-4)-2 ethyl>-3 indoles et leur utilisation comme medicaments
AR289454A AR231290A1 (es) 1981-05-22 1982-05-19 Procedimiento para obtener alquil y alquenil-3-piperidil-4-2-etil-3-indoles y sus sales
ZA823489A ZA823489B (en) 1981-05-22 1982-05-19 3-(2-(3-alkyl and alkenyl-4-piperidyl)-ethyl)-indoles and their use as medicaments
MA19687A MA19481A1 (fr) 1981-05-22 1982-05-20 (Alkyl- et alcenyl-3 piperidyl-4)-2 ethyl-3 indoles)
ES512472A ES8307242A1 (es) 1981-05-22 1982-05-21 Un procedimiento para la preparacion de 3(2-(3-alquil y alquenil-4-piperidil))indoles.
JP57086383A JPS57200385A (en) 1981-05-22 1982-05-21 3-(2-(3-alkyl and alkenyl-4-piperidyl)- ethyl)-indoles, manufacture and use as drug
AU84042/82A AU550319B2 (en) 1981-05-22 1982-05-21 3-(2-(3-alkyl and alkenyl-4 piperidyl)-ethyl)-indoles
HU821642A HU188172B (en) 1981-05-22 1982-05-21 Process for production of new derivatives of 3-/2-/ 3-alkyl or -alkemil-h-piperidil/-ethil//
DK230282A DK230282A (da) 1981-05-22 1982-05-21 3-(2-(3-alkyl og alkenyl-4-piperidyl)-ethyl)-indoler og deresanvendelse som laegemidler
NO821700A NO821700L (no) 1981-05-22 1982-05-21 3-(2-(3-alkyl og alkenyl-4-piperidyl)-etyl)-indoler.
ES521432A ES8402284A1 (es) 1981-05-22 1983-04-13 Un procedimiento para la preparacion de indoles.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8110219A FR2506310A1 (fr) 1981-05-22 1981-05-22 ((alkyl- et alcenyl-3 piperidyl-4)-2 ethyl)-3 indoles et leur utilisation comme medicaments

Publications (2)

Publication Number Publication Date
FR2506310A1 FR2506310A1 (fr) 1982-11-26
FR2506310B1 true FR2506310B1 (show.php) 1984-03-09

Family

ID=9258781

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8110219A Granted FR2506310A1 (fr) 1981-05-22 1981-05-22 ((alkyl- et alcenyl-3 piperidyl-4)-2 ethyl)-3 indoles et leur utilisation comme medicaments

Country Status (17)

Country Link
US (1) US4435410A (show.php)
EP (1) EP0065908B1 (show.php)
JP (1) JPS57200385A (show.php)
AR (1) AR231290A1 (show.php)
AU (1) AU550319B2 (show.php)
CA (1) CA1183849A (show.php)
DE (1) DE3261441D1 (show.php)
DK (1) DK230282A (show.php)
ES (2) ES8307242A1 (show.php)
FR (1) FR2506310A1 (show.php)
GR (1) GR74753B (show.php)
HU (1) HU188172B (show.php)
IL (1) IL65512A (show.php)
MA (1) MA19481A1 (show.php)
NO (1) NO821700L (show.php)
PT (1) PT74916B (show.php)
ZA (1) ZA823489B (show.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3430284A1 (de) * 1984-08-17 1986-02-27 Troponwerke GmbH & Co KG, 5000 Köln Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique
FR2634207B1 (fr) * 1988-07-12 1990-09-07 Synthelabo Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1289690A (fr) * 1960-04-01 1962-04-06 Irwin Dérivés de l'indole
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
GB1023781A (en) * 1962-02-01 1966-03-23 Benger Lab Ltd Substituted indoles and their preparation
US3471499A (en) * 1965-12-03 1969-10-07 American Home Prod 1,4-bis-(2-indol-3-yl-ethyl)piperazines
FR2334358A1 (fr) 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4208417A (en) * 1978-06-29 1980-06-17 Pharmindustrie Indole derivatives and their use as anxiolytics

Also Published As

Publication number Publication date
AU550319B2 (en) 1986-03-20
MA19481A1 (fr) 1982-12-31
ES521432A0 (es) 1984-01-16
IL65512A (en) 1985-03-31
ZA823489B (en) 1983-03-30
GR74753B (show.php) 1984-07-11
DK230282A (da) 1982-11-23
EP0065908B1 (fr) 1984-12-05
ES8402284A1 (es) 1984-01-16
PT74916A (fr) 1982-06-01
AU8404282A (en) 1982-11-25
NO821700L (no) 1982-11-23
AR231290A1 (es) 1984-10-31
US4435410A (en) 1984-03-06
DE3261441D1 (en) 1985-01-17
FR2506310A1 (fr) 1982-11-26
ES512472A0 (es) 1983-07-01
ES8307242A1 (es) 1983-07-01
HU188172B (en) 1986-03-28
IL65512A0 (en) 1982-07-30
PT74916B (fr) 1983-12-07
JPS57200385A (en) 1982-12-08
EP0065908A1 (fr) 1982-12-01
CA1183849A (fr) 1985-03-12

Similar Documents

Publication Publication Date Title
FR2501649B1 (show.php)
FR2500020B1 (show.php)
DE3278833T2 (show.php)
FR2501437B1 (show.php)
FR2502855B1 (show.php)
FR2498011B1 (show.php)
FR2501862B1 (show.php)
FR2501816B1 (show.php)
CH655527B (show.php)
FR2500222B1 (show.php)
FR2499417B1 (show.php)
FR2502169B3 (show.php)
FR2503162B1 (show.php)
FR2500202B1 (show.php)
FR2502675B3 (show.php)
FR2502466B1 (show.php)
FR2502087B1 (show.php)
FR2501772B3 (show.php)
FR2503404B1 (show.php)
FR2500334B3 (show.php)
FR2497909B1 (show.php)
FR2497744B1 (show.php)
FR2497957B1 (show.php)
FR2500357B3 (show.php)
FR2498415B1 (show.php)

Legal Events

Date Code Title Description
ST Notification of lapse